Posted 17 March 2015
By Stewart Eisenhart, Emergo
Content provided by Emergo, a medical device regulatory affairs and quality assurance consulting firm with offices worldwide.
South Korea’s medical device market regulator, the Ministry of Food and Drug Safety (MFDS), will begin requiring clinical data for dozens of medical devices in January 2016 that currently can avoid such requirements if their equivalence to predicate devices already on the South Korean market can be shown.
Among the proposed list of device categories (link in Korean) for which MFDS plans to require clinical data in order to obtain market registration are:
|MFDS clinical data requirements for high-risk medical devices in South Korea|
|Implantable pacemakers||Spinal internal fixation systems|
|Antitremor electrical stimulation systems||Mandibular prostheses|
|Implantable defibrillators||Iliac stents|
|Balloon catheters for cardiac treatments||Neurovascular stents|
|Laser angioplasty catheters||Saline breast prostheses|
|Implantable infusion pumps||Multifocal intraocular lenses|
According to Emergo consultants in Seoul, all affected devices fall under the Class IV high-risk classification; the new requirements will only apply to future registrations.
For all affected devices, registrants will need to provide clinical data in addition to technical dossiers in Summary Technical Document (STED) format.
Original Post at Emergo
Related Post: South Korea Regulators Scale Back KGMP Inspection Requirements
Related Post: All Class I Devices Now Exempt from Korea GMP Requirements